RetinalGenix Technologies Inc. Share Price
Stocks
RTGN
US76133Y1055
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
OTC Markets
18:46:02 30/10/2025 GMT
|
5-day change | 1st Jan Change | ||
| 3.550 USD | -11.25% |
|
-11.03% | +10.94% |
| Market Cap | 75.19M 67.34M 61.94M 56.12M 105M 7.14B 107M 739M 297M 3.76B 282M 276M 11.84B | P/E 2024 |
-21.8x | P/E 2025 | -24.5x |
|---|---|---|---|---|---|
| Enterprise Value | 75.72M 67.81M 62.38M 56.52M 106M 7.19B 108M 744M 299M 3.78B 284M 278M 11.93B | EV / Sales 2024 |
-
| EV / Sales 2025 | - |
| Free-Float |
34.7% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | -11.25% | ||
| 1 week | -11.03% | ||
| Current month | -11.03% | ||
| 1 month | -11.03% | ||
| 3 months | -11.25% | ||
| 6 months | +10.94% | ||
| Current year | +10.94% |
| Current year | 3.55 |  | 4 |
| 1 year | 3.2 | | 4 |
| 3 years | 0.25 | | 6.36 |
| 5 years | 0.25 | | 20 |
| 10 years | 0.25 | | 20 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jerry Katzman
CEO | Chief Executive Officer | 73 | 30/11/2018 |
| Director | Title | Age | Since |
|---|---|---|---|
Jerry Katzman
CHM | Chairman | 73 | 30/11/2018 |
Herbert Gould
BRD | Director/Board Member | 97 | 31/03/2019 |
Vinay Mehindru
BRD | Director/Board Member | 58 | 25/07/2022 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -11.25% | -11.03% | -.--% | -20.94% | 75.19M | |
| -0.62% | -1.87% | +42.87% | +64.15% | 63.77B | |
| +0.35% | +3.20% | +14.40% | +81.76% | 56.37B | |
| +0.53% | +1.96% | +16.24% | +103.35% | 54.62B | |
| -2.81% | -4.31% | +23.50% | +47.83% | 44.06B | |
| -0.33% | -1.93% | +19.28% | +98.80% | 42.11B | |
| +0.55% | +2.31% | +225.14% | +866.21% | 41B | |
| +3.27% | +47.96% | +112.84% | +96.58% | 34.92B | |
| +1.22% | -1.44% | +14.57% | +46.95% | 32.82B | |
| +0.89% | +20.55% | -40.62% | +349.24% | 24.7B | |
| Average | -0.82% | +6.79% | +42.82% | +173.39% | 39.44B | |
| Weighted average by Cap. | +0.18% | +5.44% | +47.98% | +176.63% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | - | - |
| Net income | -4.32M -3.87M -3.56M -3.23M -6.03M -410M -6.14M -42.45M -17.04M -216M -16.22M -15.87M -681M | -2.43M -2.18M -2M -1.81M -3.39M -231M -3.45M -23.86M -9.58M -121M -9.11M -8.92M -383M |
| Net Debt | 518K 464K 427K 387K 723K 49.21M 737K 5.09M 2.04M 25.89M 1.94M 1.9M 81.63M | 530K 475K 437K 396K 739K 50.32M 753K 5.21M 2.09M 26.47M 1.99M 1.95M 83.48M |
Employees
-
- Stock Market
- Stocks
- RTGN Stock
Select your edition
All financial news and data tailored to specific country editions
